- Signals mixed outlook causing market dips involving the FED and Nasdaq.
- Hawkish signals from the Fed are impacting market sentiment and influencing the performance of the tech sector, including companies like Amazon and Broadcom.
Financial firms reaffirmed and updated ratings and price targets for Broadcom stock.
2 reports, 2 independent
Updated Jul 9
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Financial firms reaffirmed and updated ratings and price targets for Broadcom stock.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Erste Group downgraded Broadcom, while UBS and Bank of America issued updated ratings and forecasts.1 source
Analysts reaffirmed buy/outperform ratings and set new price targets for Broadcom.1 source
Keep exploring
The entities involved
-
Broadcom
American semiconductor manufacturer
-
Morgan Stanley
U.S. investment bank
Related events
- Bell Bank increased its holdings in Broadcom shares on October 24, 2026.
- Morgan Stanley and Jefferies Financial Group raised price targets and upgraded shares for DT Midstream, Inc., following institutional filings with the SEC.
- Broadcom is accelerating shipments of units for Google, including those related to Ironwood, while Cantor Fitzgerald analysts have raised their price targets.
- A major IPO is expected to list several key AI suppliers and investors, including Nvidia, Broadcom, and Google, on Nasdaq.
- Raymond James Financial reaffirmed a strong-buy rating and Morgan Stanley set a $25.00 price objective for VIR Biotechnology.